Literature DB >> 11385777

Carcinoma of the cervix uteri.

J L Benedet1, F Odicino, P Maisonneuve, U Beller, W T Creasman, A P Heintz, H Y Ngan, M Sideri, S Pecorelli.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11385777

Source DB:  PubMed          Journal:  J Epidemiol Biostat        ISSN: 1359-5229


× No keyword cloud information.
  28 in total

1.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

2.  The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.

Authors:  A L Valentini; M Miccò; B Gui; M Giuliani; E Rodolfino; A M Telesca; T Pasciuto; A Testa; M A Gambacorta; G Zannoni; V Rufini; A Giordano; V Valentini; G Scambia; R Manfredi
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

3.  Markers of apoptosis in stage IB squamous cervical carcinoma.

Authors:  G Van de Putte; R Holm; A K Lie; M Baekelandt; G B Kristensen
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

4.  Ovarian recurrence from a Stage 1b1 cervical adenocarcinoma previously treated with radical vaginal trachelectomy: A case report.

Authors:  E C Brockbank; J Evans; N Singh; J H Shepherd; A R Jeyarajah
Journal:  Gynecol Oncol Case Rep       Date:  2012-01-16

5.  Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.

Authors:  Hyun Hoon Chung; Byung-Ho Nam; Jae Weon Kim; Keon Wook Kang; Noh-Hyun Park; Yong-Sang Song; June-Key Chung; Soon-Beom Kang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-30       Impact factor: 9.236

6.  Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy.

Authors:  Junko Haraga; Keiichiro Nakamura; Chiaki Omichi; Takeshi Nishida; Tomoko Haruma; Tomoyuki Kusumoto; Noriko Seki; Hisashi Masuyama; Norihisa Katayama; Susumu Kanazawa; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2016-09-21

7.  The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.

Authors:  LingLing Pan; JingYi Cheng; Min Zhou; ZhiFeng Yao; YingJian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-20       Impact factor: 4.553

Review 8.  Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.

Authors:  Larysa Rydzewska; Jayne Tierney; Claire L Vale; Paul R Symonds
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

9.  NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma.

Authors:  Lina Gu; Bairong Xia; Lili Zhong; Yuan Ma; Lei Liu; Liping Yang; Ge Lou
Journal:  Tumour Biol       Date:  2014-05-13

10.  Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.

Authors:  E R Nijhuis; H W Nijman; K A Oien; A Bell; K A ten Hoor; N Reesink-Peters; H M Boezen; H Hollema; A G J van der Zee
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.